Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2

20 Jul 2016

Abstract excerpt

// Henan Zhao 1 , Xiaotang Yu 1 , Yanfang Ding 1 , Jinyao Zhao 1 , Guang Wang 1 , Xian Wu 1 , Jiyong Jiang 2 , Chun Peng 3 , Gordon Zhuo Guo 4 , Shiying Cui 1 1 Dalian Medical University, Dalian, China 2 Obstetrics and Gynecology Hospital, Dalian, China 3 Department of Biology, York University, Toronto, Canada 4 Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, USA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to MicroRNA in disease regulation
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27449101
DOI: 10.18632/oncotarget.10736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2PMID 27449101Read ↗

MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cellsSemantic proximity Read ↗

Molecular mechanisms of cisplatin resistance in ovarian cancerSemantic proximity Read ↗

Evaluation of Long Non-coding RNA (LncRNA) in the Pathogenesis of Chemotherapy Resistance in Cervical Cancer: Diagnostic and Prognostic ApproachSemantic proximity Read ↗

Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repairSemantic proximity Read ↗

Identification of prognostic genes after platinum-based chemotherapy in ovarian cancerSemantic proximity Read ↗

MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathwaysSemantic proximity Read ↗

Deciphering the role of miR-506 in ovarian cancer drug sensitivitySemantic proximity Read ↗

CD147 promotes cisplatin resistance in ovarian cancer by inhibiting FOXM1 degradation via PI3k/Akt-GSK3β pathwaySemantic proximity Read ↗

Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.Semantic proximity Read ↗

Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line.Semantic proximity Read ↗

The role of microRNA in cisplatin resistance or sensitivitySemantic proximity Read ↗

Tyrosine kinase receptor TIE-1 mediates platinum resistance by promoting nucleotide excision repair in ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.